Navigation Links
Experts tackle shipment issues for beneficial radiation sources
Date:5/16/2008

Delays and denials of shipments involving regulated radioactive materials used in medicine and industry are of growing concern to safety and industry experts. Meeting in Rome this week at an IAEA workshop, they agreed on an action plan for the Mediterranean region that seeks to ease hardships for hospitals, research centres and organizations that rely on timely delivery of beneficial radiation sources.

The shipment issues have surfaced over the past several years, with international dimensions. Data reported to the IAEA over a recent six-month period indicate more delays than denials are taking place. Denials block shipments entirely, and delays can virtually render a radioisotope useless because of its short radioactive half-life.

Between September 2007 and March 2008, a total of 69 reports of delays and denials of shipments (42 delays, 19 denials and 8 unspecified) were reported to the IAEA. Of these, 46 reports concerned air transport, while the remaining 23 cases concerned sea, rail and road transport modes. In terms of the most common types of radioactive sources involved, 23 reports concerned iodine-131 (which has a half-life of eight days and is used in medical diagnosis), 14 fluorodeoxyglucose (a solution used for medical imaging incorporating fluorene-18, which has a half-life of just under 110 minutes); and 13 cobalt-60 (which has a half-life of 5.27 years and is used in radiotherapy for cancer care, among other applications).

The main outputs of the Rome workshop are the establishment of:

  • A regional action plan focusing on six areas (i.e. awareness, training, communication, lobbying, economic, and harmonization);

  • A regional network that would allow participants to share their experience and lessons learned, as well as identify and disseminate best practices; and

  • A regional database of denial of shipments instances that will help identify issues and trends in a consistent and reliable manner.

The participants also stressed that successful communication and strong cooperation between a range of partners is essential for eventually resolving problems. Partners include the International Steering Committee on Denial of Shipments, the IAEA, the UN and International Modal Organizations, trade associations, regional networks, and national focal points in each country will lead to a better understanding and, eventually, a resolution of this problem. The workshop was hosted by the Government of Italy through the National Agency for Environmental Protection and Technical Services (APAT).

At the workshop, the IAEAs Khammar Mrabit, Head of the Regulatory Infrastructure and Transport Safety Section, highlighted the importance of tackling the issue of denial of shipments of radioactive material, emphasizing the importance of international safety standards and practices.

"There has been no significant accident from transport of radioactive material over the past half century," he said. "Denial of shipments potentially increases the risks to safety and security. We should not let the issue of denial of shipments of radioactive material render ineffective the good work that has been done for over 50 years of establishing a strong safety record."

In his welcome remarks, Roberto Mezzanotte, Director of APATs Department of Nuclear, Technological and Industrial Risk, also emphasized the urgency of the problem. "The issue of denial of shipments is not just for specialists but affects the lives of millions of people around the world. The majority of the radioactive material shipped every day is used in hospitals for diagnostics and treatment of several illnesses," he said.

The three-day Regional Workshop on Denial of Shipment of Radioactive Material for Countries in the Mediterranean Basin was held in Rome, Italy, from 14-16 May. More than 80 participants from 15 countries of the Mediterranean Basin and eight international organizations and associations attended. The workshop was part of the IAEAs response to reports of increasing numbers of instances of radioactive material being denied shipment by carriers, and followed a similar meeting in Montevideo, Uruguay, in July 2007 for the Latin American region. Three more workshops are scheduled for June 2008 in Africa, Asia and the Pacific.

Background

Production of isotopes is limited to a few countries, which underscores the importance of timely, efficient and safe international shipments to hospitals and industries. Some radioisotopes, such as iodine-123 - used for heart and thyroid imaging - have a half-life of only hours. Consequently, any interruption to their delivery can threaten the medical care of patients.

According to industry statistics 85,000 nuclear medicine procedures are carried out around the world every day. Additionally, radioactive material shipped every day all over the world is also used in a multitude of industrial applications, research and development, and in the generation of electricity and power.


'/>"/>

Contact: Giovanni Verlini
G.VERLINI@iaea.org
43-126-002-1281
International Atomic Energy Agency
Source:Eurekalert

Related biology news :

1. IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization
2. Sudden ecosystem flips imperil worlds poorest regions, say water experts
3. Experts prove the geochemical origin of part of the CO2 emissions in semiarid climates
4. Leading researchers and experts gather to discuss latest advancements in drug discovery
5. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
6. Experts from Stevens, Merck, publish joint paper, Biosynthetic Studies of Platensimycin
7. Agriculture experts meet in Beijing to examine impacts of food prices and climate change on farmers
8. Now is Africas turn for a green revolution, global experts say
9. Soil, conservation experts to reflect on Hurricane Katrina disaster
10. Less Arctic ice means higher risks, experts warn
11. Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):
(Date:6/22/2016)... 22, 2016  According to Kalorama Information, the ... (NGS) market include significant efforts in automation as ... accessible and affordable sequencers, say the healthcare market ... consumables including sample prep materials.  The healthcare market ... Preparation for Next Generation Sequencing (NGS) , highlights ...
(Date:6/22/2016)... DIEGO , June 22, 2016   ViaCyte, ... first pluripotent stem cell-derived islet replacement therapy for the ... presentations at ISSCR 2016 Annual Meeting.  ISSCR 2016, the ... to 25th at Moscone West in San Francisco.  ... of the presentations are as follows:Event: , Focus Session: ...
(Date:6/22/2016)... June 22, 2016  Mesa Biotech Inc., a ... testing platform designed specifically for point-of-care (POC) infectious ... scientific advisory board (SAB). Approved by the executive ... is chartered to advise on the development and ... Led by Dr. Steve Young , this ...
(Date:6/21/2016)... , June 22, 2016 Frontier Biotechnologies Inc. ... its novel patch product AB001 met primary endpoint at ... relief against placebo. Conducted at nine clinical centers in ... enrolled 146 patients with chronic low back pain. AB001 ... week-1 (p=0.024), (2) greater reduction than placebo in the ...
Breaking Biology Technology: